ESC Premium Access

Utilization and effectiveness of alirocumab and evolocumab in improving lipid profile in routine clinical practice

Topic: Lipids (Epidemiology and Prevention)

Congress Presentation

About the speaker

Doctor Peter Noseworthy

Mayo Clinic, Rochester (United States of America)
3 presentations
0 follower

14 more presentations in this session

Impact of the european and american guidelines on the management and treatment of dyslipidemia in a spanish working population

Speaker: Doctor C. Brotons (Barcelona, ES)


Management of hypercholesterolaemia in non-Western countries and achievement of LDL-C goals: an international, cross-sectional, observational study

Speaker: Professor N. Danchin (Paris, FR)


Lipid goals are poorly attained in majority of patients with familial hypercholesterolemia in Latvia at the time of inclusion in the national registry

Speaker: Professor G. Latkovskis (Riga, LV)


The metabolism of triglyceride-rich lipoproteins is impaired in patients with obstructive sleep apnoea: effects of treatment with continuous positive airway pressure.

Speaker: Associate Professor L. Drager (Sao Paulo, BR)


Clinical characteristics and cardiovascular outcomes in subjects who developed acute myocardial infarction despite statin therapy.

Speaker: Doctor K. Tsuda (Takatsuki, JP)


Access the full session

Poster session 7 - Lipids

Speakers: Doctor P. Noseworthy, Doctor C. Brotons, Professor N. Danchin, Professor G. Latkovskis, Associate Professor L. Drager...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb